Stride Arcolab’s specialties subsidiary Agila Specialists (Malaysia) and Malaysian Bio-XCell, the investment arm of Malaysian Biotechnology Corporation, has exchanged agreement for the establishment of a customized facility to manufacture biopharmaceuticals and sterile injectables in the Bio-Xcell ecosystem in Johor, Malaysia.
The agreement was exchanged by Adam Levitt, CEO-Americas of Strides Arcolab and Raja Ridzwa Raja Abdul Aziz, CEO of Bio-XCell in the presence of Tan Myhyiddin Yassin, Deputy Price Minister of Malaysia during the Bio Intentional Convention 2011 in Washington DC.
The project will be built by Bio-Xcell to the design requirements of Strides and will be leased out to Strides on a long-term basis. The lease rentals are applicable from the date of commercialization which supports the biotech strategy of Strides where there is a long gestation period from development to commercialization.
Strides Arcolab is a global pharmaceuticals company headquartered in Banglore, India that develops and manufactures wide range of IP-led niche pharmaceuticals products with an emphasis on sterlite injectables.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1841.80 |
Dr. Reddys Lab | 1199.70 |
Cipla | 1554.40 |
Lupin | 2107.70 |
Zydus Lifesciences | 885.85 |
View more.. |